A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT04923347 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: FF/UMEC/VI
DEVICE: ELLIPTA

Sponsor

GlaxoSmithKline